BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10354136)

  • 21. Biological characteristics of CD7 positive acute myelogenous leukaemia.
    Eto T; Akashi K; Harada M; Shibuya T; Takamatsu Y; Teshima T; Niho Y
    Br J Haematol; 1992 Nov; 82(3):508-14. PubMed ID: 1283077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular characteristics of chronic myelocytic leukemia basophilic crisis cells: phenotype, responsiveness to and receptor gene expression for various kinds of growth factors and cytokines.
    Shimizu N; Kita K; Masuya M; Nishii K; Matsuoka N; Morita N; Miwa H; Shirakawa S
    Exp Hematol; 1993 Jan; 21(1):119-25. PubMed ID: 7678084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children.
    Hurwitz CA; Raimondi SC; Head D; Krance R; Mirro J; Kalwinsky DK; Ayers GD; Behm FG
    Blood; 1992 Dec; 80(12):3182-8. PubMed ID: 1467524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic analysis of 8;21 chromosomal translocation without AML1 gene involvement in MDS-AML.
    Kawano S; Miyanishi S; Shimizu K; Tanaka K; Okumura A; Ohki M; Kamada N; Ohno Y
    Br J Haematol; 1997 Dec; 99(3):632-40. PubMed ID: 9401077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and functional analysis of granulocyte colony-stimulating factor receptors on CD34++ cells in patients with myelodysplastic syndrome (MDS) and MDS-acute myeloid leukaemia.
    Sultana TA; Harada H; Ito K; Tanaka H; Kyo T; Kimura A
    Br J Haematol; 2003 Apr; 121(1):63-75. PubMed ID: 12670333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunophenotypic analysis of acute myeloid leukemia with t(8;21)].
    Fan L; Wu YJ; Zhang JF; Qiu HR; Qiao C; Wang R; Yang H; Xu W; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1410-3. PubMed ID: 21176340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of interleukin-2 receptor alpha chain expression of immature acute myelocytic leukemia cells.
    Nakase K; Kita K; Anazawa H; Hoshino K; Shirakawa S; Tanaka I; Tsudo M
    Leuk Res; 1994 Apr; 18(4):269-74. PubMed ID: 7513371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
    Gazzola MV; Collins NH; Tafuri A; Keever CA
    Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of serum deprivation on constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells.
    Uemura Y; Kobayashi M; Nakata H; Harada R; Kubota T; Taguchi H
    Int J Cancer; 2004 May; 109(6):826-32. PubMed ID: 15027115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in nonhematopoietic human malignant cell lines.
    Guillaume T; Sekhavat M; Rubinstein DB; Hamdan O; Symann ML
    Cancer Res; 1993 Jul; 53(13):3139-44. PubMed ID: 8319222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth factor receptor profile of CD34+ cells in AML and B-lineage ALL and in their normal bone marrow counterparts.
    De Waele M; Renmans W; Vander Gucht K; Jochmans K; Schots R; Otten J; Trullemans F; Lacor P; Van Riet I
    Eur J Haematol; 2001 Mar; 66(3):178-87. PubMed ID: 11350486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-11 (IL-11) acts as a synergistic factor for the proliferation of human myeloid leukaemic cells.
    Lemoli RM; Fogli M; Fortuna A; Amabile M; Zucchini P; Grande A; Martinelli G; Visani G; Ferrari S; Tura S
    Br J Haematol; 1995 Oct; 91(2):319-26. PubMed ID: 8547068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.
    Noort S; Zimmermann M; Reinhardt D; Cuccuini W; Pigazzi M; Smith J; Ries RE; Alonzo TA; Hirsch B; Tomizawa D; Locatelli F; Gruber TA; Raimondi S; Sonneveld E; Cheuk DK; Dworzak M; Stary J; Abrahamsson J; Arad-Cohen N; Czogala M; De Moerloose B; Hasle H; Meshinchi S; van den Heuvel-Eibrink M; Zwaan CM
    Blood; 2018 Oct; 132(15):1584-1592. PubMed ID: 30150206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment and characterization of a novel acute myeloid leukemia cell line, JIH-4, carrying a t(16;21)(p11.2;q22) and expressing the FUS-ERG fusion.
    Jiang H; Qiu H; Xue Y; Pan J; Wu Y; Zhang J; Zheng J; Wang Q; Liang J; Chen S
    Cancer Genet; 2011 Apr; 204(4):219-23. PubMed ID: 21536242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel cell line derived from de novo acute myeloblastic leukaemia with trilineage myelodysplasia which proliferates in response to a Notch ligand, Delta-1 protein.
    Tohda S; Sakano S; Ohsawa M; Murakami N; Nara N
    Br J Haematol; 2002 May; 117(2):373-8. PubMed ID: 11972520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of minimal residual disease in a patient having acute myelogenous leukemia with t(16;21)(p11;q22) treated by allogeneic bone marrow transplantation.
    Okoshi Y; Shimizu S; Kojima H; Obara N; Mukai HY; Komeno T; Hasegawa Y; Mori N; Nagasawa T
    Acta Haematol; 2001; 105(1):45-8. PubMed ID: 11340253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment of an undifferentiated leukemia cell line (Kasumi-3) with t(3;7)(q27;q22) and activation of the EVI1 gene.
    Asou H; Suzukawa K; Kita K; Nakase K; Ueda H; Morishita K; Kamada N
    Jpn J Cancer Res; 1996 Mar; 87(3):269-74. PubMed ID: 8613429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two childhood cases of acute leukemia with t(16;21)(p11.2;q22): second case report of infantile acute lymphoblastic leukemia with unusual type of FUS-ERG chimeric transcript.
    Oh SH; Park TS; Choi JR; Lee S; Cho SY; Kim SY; Kim J; Park JK; Song SA; Lee JY; Shin JH; Kim HR; Lee JN
    Cancer Genet Cytogenet; 2010 Jul; 200(2):180-3. PubMed ID: 20620604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7.
    Orlic D; Anderson S; Biesecker LG; Sorrentino BP; Bodine DM
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4601-5. PubMed ID: 7538677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular characteristics of acute myeloblastic leukemia associated with t(8;21)(q22;q22). The Japanese Cooperative Group of Leukemia/Lymphoma.
    Kita K; Shirakawa S; Kamada N
    Leuk Lymphoma; 1994 Apr; 13(3-4):229-34. PubMed ID: 8049646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.